MGF peptide replication study in myoblasts and muscle stem cells
The investigators found no apparent proliferative or differentiation effect and questioned earlier claims for the peptide.
What this study tells us
This was laboratory research in cultured cells, including human myoblasts and mouse muscle stem cells. It did not administer PEG-MGF to people or animals as a treatment, so it can challenge a mechanism claim but cannot establish clinical benefit or safety.
C2C12 cells, primary human myoblasts and mouse muscle stem cells
No participant count — this was laboratory or analytical research.
The investigators found no apparent proliferative or differentiation effect and questioned earlier claims for the peptide.
Not PEG-MGF; nevertheless it is important conflicting evidence against transferring a simple MGF growth narrative to commercial products.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
The investigators found no apparent proliferative or differentiation effect and questioned earlier claims for the peptide.